Shahram Hakimelahi

651 total citations
15 papers, 459 citations indexed

About

Shahram Hakimelahi is a scholar working on Organic Chemistry, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Shahram Hakimelahi has authored 15 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Molecular Medicine. Recurrent topics in Shahram Hakimelahi's work include Synthesis and Catalytic Reactions (4 papers), Antibiotic Resistance in Bacteria (4 papers) and Synthesis of β-Lactam Compounds (3 papers). Shahram Hakimelahi is often cited by papers focused on Synthesis and Catalytic Reactions (4 papers), Antibiotic Resistance in Bacteria (4 papers) and Synthesis of β-Lactam Compounds (3 papers). Shahram Hakimelahi collaborates with scholars based in Taiwan, Iran and Canada. Shahram Hakimelahi's co-authors include Linda M. Phillips, Sandra M. Guilbert, Martha L. Smith, Stephen P. Norris, G. H. HAKIMELAHI, Manijeh Pasdar, Ali Akbar Moosavi‐Movahedi, Zhi Li, R. Chris Bleackley and Michèle Barry and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

Shahram Hakimelahi

14 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shahram Hakimelahi Taiwan 10 134 112 109 69 42 15 459
Xiaorong Xia China 8 40 0.3× 61 0.5× 47 0.4× 62 0.9× 15 0.4× 13 365
Brian J. Girard United States 10 92 0.7× 28 0.3× 114 1.0× 25 0.4× 50 1.2× 14 333
R. M. ADLINGTON Australia 9 98 0.7× 30 0.3× 96 0.9× 24 0.3× 19 0.5× 25 271
Yuko Iwai United States 12 172 1.3× 165 1.5× 117 1.1× 81 1.2× 21 0.5× 25 569
Ana María de Caso Fuertes Spain 13 288 2.1× 112 1.0× 199 1.8× 82 1.2× 23 0.5× 52 765
Michael Peterson United States 6 92 0.7× 55 0.5× 284 2.6× 57 0.8× 115 2.7× 12 568
Robert Farrell United States 14 68 0.5× 260 2.3× 33 0.3× 28 0.4× 55 1.3× 35 624
María del Mar Sánchez Vera Spain 15 32 0.2× 41 0.4× 218 2.0× 54 0.8× 40 1.0× 67 567
Robert P. Parker United States 15 106 0.8× 75 0.7× 167 1.5× 61 0.9× 19 0.5× 42 655
Derek C. Braun United States 12 134 1.0× 24 0.2× 70 0.6× 38 0.6× 27 0.6× 14 344

Countries citing papers authored by Shahram Hakimelahi

Since Specialization
Citations

This map shows the geographic impact of Shahram Hakimelahi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahram Hakimelahi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahram Hakimelahi more than expected).

Fields of papers citing papers by Shahram Hakimelahi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahram Hakimelahi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahram Hakimelahi. The network helps show where Shahram Hakimelahi may publish in the future.

Co-authorship network of co-authors of Shahram Hakimelahi

This figure shows the co-authorship network connecting the top 25 collaborators of Shahram Hakimelahi. A scholar is included among the top collaborators of Shahram Hakimelahi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahram Hakimelahi. Shahram Hakimelahi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Norris, Stephen P., Sandra M. Guilbert, Martha L. Smith, Shahram Hakimelahi, & Linda M. Phillips. (2005). A theoretical framework for narrative explanation in science. Science Education. 89(4). 535–563. 193 indexed citations
2.
HAKIMELAHI, G. H., Pai‐Chi Li, Ali Akbar Moosavi‐Movahedi, et al.. (2003). Application of the Barton photochemical reaction in the synthesis of 1-dethia-3-aza-1-carba-2-oxacephem: a novel agent against resistant pathogenic microorganisms. Organic & Biomolecular Chemistry. 1(14). 2461–2461. 12 indexed citations
3.
Moosavi‐Movahedi, Ali Akbar, Shahram Hakimelahi, Jamshidkhan Chamani, et al.. (2003). Design, synthesis, and anticancer activity of phosphonic acid diphosphate derivative of adenine-containing butenolide and its water-soluble derivatives of paclitaxel with high antitumor activity. Bioorganic & Medicinal Chemistry. 11(20). 4303–4313. 55 indexed citations
4.
HAKIMELAHI, G. H., Kak‐Shan Shia, Manijeh Pasdar, et al.. (2002). Design, synthesis, and biological evaluation of a cephalosporin–monohydroguaiaretic acid prodrug activated by a monoclonal antibody–β-lactamase conjugate. Bioorganic & Medicinal Chemistry. 10(9). 2927–2932.
5.
HAKIMELAHI, G. H., Ali Akbar Moosavi‐Movahedi, Thota Sambaiah, et al.. (2002). Reactions of purines-containing butenolides with l-cysteine or N-acetyl-l-cysteine as model biological nucleophiles: a potent mechanism-based inhibitor of ribonucleotide reductase caused apoptosis in breast carcinoma MCF7 cells. European Journal of Medicinal Chemistry. 37(3). 207–217. 14 indexed citations
6.
HAKIMELAHI, G. H., Kak‐Shan Shia, Cuihua Xue, et al.. (2002). Design, Synthesis, and Biological Evaluation of a Series of β-Lactam-Based Prodrugs. Bioorganic & Medicinal Chemistry. 10(11). 3489–3498. 14 indexed citations
7.
HAKIMELAHI, G. H., et al.. (2002). A Novel Approach towards Studying Non-Genotoxic Enediynes as Potential Anticancer Therapeutics. Bioorganic & Medicinal Chemistry. 10(5). 1321–1328. 10 indexed citations
8.
HAKIMELAHI, G. H., Tai Wei Ly, Ali Akbar Moosavi‐Movahedi, et al.. (2001). Design, Synthesis, and Biological Evaluation of Novel Nucleoside and Nucleotide Analogues as Agents against DNA Viruses and/or Retroviruses. Journal of Medicinal Chemistry. 44(22). 3710–3720. 39 indexed citations
9.
HAKIMELAHI, G. H., Ali Akbar Moosavi‐Movahedi, Shwu‐Chen Tsay, et al.. (2001). ChemInform Abstract: Design, Synthesis, and SAR of Novel Carbapenem Antibiotics with High Stability to Xanthomonas maltophilia Oxyiminocephalosporinase Type II (CXase‐II).. ChemInform. 32(10). 1 indexed citations
10.
HAKIMELAHI, G. H., et al.. (2001). Synthesis and Biological Evaluation of Purine-Containing Butenolides. Journal of Medicinal Chemistry. 44(11). 1749–1757. 18 indexed citations
11.
Hakimelahi, Shahram, et al.. (2000). Plakoglobin Regulates the Expression of the Anti-apoptotic Protein BCL-2. Journal of Biological Chemistry. 275(15). 10905–10911. 78 indexed citations
12.
HAKIMELAHI, G. H., Ali Akbar Moosavi‐Movahedi, Shwu‐Chen Tsay, et al.. (2000). Design, Synthesis, and SAR of Novel Carbapenem Antibiotics with High Stability to Xanthomonas maltophilia Oxyiminocephalosporinase Type II. Journal of Medicinal Chemistry. 43(20). 3632–3640. 13 indexed citations
13.
Hwu, Jih Ru, Shahram Hakimelahi, Ali Akbar Moosavi‐Movahedi, & Jih Ru Hwu. (1999). Concept of Counterattack Reagents: Intramolecular Counterattack Strategy in the Synthesis of Biologically Active Isopenams. Chemistry - A European Journal. 5(9). 2705–2711. 5 indexed citations
14.
Hwu, Jih Ru, Shahram Hakimelahi, Kuang‐Lieh Lu, & Shwu‐Chen Tsay. (1999). Different roles of trifluoromethanesulfonyl chloride in the construction of heterocycles fused with β-lactams. Tetrahedron. 55(26). 8039–8044. 3 indexed citations
15.
Hwu, Jih Ru, Shwu‐Chen Tsay, & Shahram Hakimelahi. (1998). Syntheses of New Isodethiaazacephems as Potent Antibacterial Agents. Journal of Medicinal Chemistry. 41(24). 4681–4685. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026